Browsing Tag
biotech
205 posts
Reversing AI drug discovery: Belgian biotech Sightera raises €3M to learn from ‘extreme’ patient biology first
Most AI drug discovery companies start by selecting a target and designing a molecule, then seeking biological validation.…
July 17, 2026
CriteriaCaixa’s venture arm eyes €300M for AI, photonics and biotech across Spain and Portugal
Most venture funds work against the clock. Raise, deploy, exit, repeat, usually within a decade. CriteriaCaixa‘s investment arm…
July 13, 2026
Visibuilt raises €3.3M from EIFO and Unconventional Ventures to grow roads from fungi instead of paving them with oil
Line Kloster Pedersen was running around Copenhagen’s lakes when she looked down at the soil and wondered why…
July 13, 2026
A Cambridge PhD discovery raised £1.5M led by SCVC to fix gene therapy’s costly flaw
Houdini Bio just raised about £1.5 million by combining non-dilutive grants, which do not require giving up equity,…
June 19, 2026
Why your ELISA kit works in the vendor’s lab but not yours
Enzyme-Linked Immunosorbent Assay (ELISA) is a highly reliable technique used by researchers to measure biomarkers in samples. Precise…
June 15, 2026
How biochemical supply chains are becoming a competitive advantage for biotech startups
Laboratory work depends on materials that arrive stable, documented, and ready for controlled use. Weak supply practices can…
June 5, 2026
London biotech raises $53M to decode the immune system using a single blood sample
Doctors can sequence your entire genome. They still cannot fully read your immune system, the biological layer that…
June 2, 2026
Ada Ventures, Antler back Alcolase in €1.5M round to develop enzyme treatment for alcohol intolerance
Alcolase, a biotech company based in Copenhagen, has raised €1.5 million from Ada Ventures, Delphinus Venture Capital, Antler,…
May 18, 2026
Pitch deck: Tolemy Bio raises €1.4M from Norrsken Evolve to build the ‘Google Maps for cells.’
Britain’s Tolemy Bio has closed a €1.4 million pre-seed round led by Norrsken Evolve. The company focuses on…
May 12, 2026